Sort
34,240 grants matching “atherosclerosis”
LOX-1 as a protective countermeasure in response to lung infection
$742,474Lee Quinton · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · HL
Acetate and Endothelial Pathobiology
$742,438Zoltan P Arany · University Of Pennsylvania · R01 · FY2023 · HL
Gene Therapy in Hutchinson-Gilford Progeria Syndrome
$742,403Jonathan David Brown · Vanderbilt University Medical Center · R01 · FY2022 · HL
Radiomics-based risk prediction of heart failure using CT calcium score exam
$742,395Shuo Li · Case Western Reserve University · R01 · FY2025 · HL
VISCERAL FAT, METABOLIC RATE AND CVD IN YOUNG ADULTS
$742,387Kaiser Foundation Hospitals · R01 · FY2000 · HL
Persistent HIV expression induced type I IFN responses and inflammaging
$742,299Suryaram Gummuluru · Boston University Medical Campus · R01 · FY2020 · AG
Comprehensive Magnetic Resonance in PAD
$742,250University Of Virginia Charlottesville · R01 · FY2004 · HL
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
$742,178Richard P Sloan · Columbia University Health Sciences · R01 · FY2011 · HL
Multimodal genetic regulatory architecture of coronary artery disease
$742,087Clint L Miller · University Of Virginia · R01 · FY2024 · HL
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PAD
$742,059Brian H Annex · Augusta University · R01 · FY2021 · HL
Unexpectedly Profound Role of Water in Biology and Medicine
$742,005Gerald H Pollack · University Of Washington · R01 · FY2011 · GM
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$741,784Thomas H Mosley · University Of Mississippi Med Ctr · N01 · FY2017 · HL
Natural History of Smoking & Quitting: Longterm Outcomes
$741,702Michael C Fiore · University Of Wisconsin-Madison · P50 · FY2008 · DA
Influence of T cell genotype/phenotype in atherosclerotic cardiovascular disease
$741,684Richard J Gumina · Ohio State University · R01 · FY2023 · HL
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for Aging
$741,606Birgit Schilling · Buck Institute For Research On Aging · U01 · FY2022 · AG
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for Aging
$741,606Birgit Schilling · Buck Institute For Research On Aging · U01 · FY2019 · AG
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for Aging
$741,606Birgit Schilling · Buck Institute For Research On Aging · U01 · FY2021 · AG
Innate and adaptive immune-cell densities as risk factors for heart failure
$741,580Bruce M Psaty · University Of Washington · R01 · FY2018 · HL
Magnetic Resonance in Peripheral Arterial Disease
$741,424Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2007 · HL
ARTERIAL ENDOTHELIAL FUNCTION--AN EPIDEMIOLOGIC STUDY
$741,381Trudy L Burns · University Of Iowa · R01 · FY2008 · HL
Identifying Early Intervention Targets for Reducing Cardiovascular Risk in Posttraumatic Stress
$741,359Jennifer A Sumner · University Of California Los Angeles · R01 · FY2022 · HL
Quantitative Trait Locus Mapping in Human Pedigrees
$741,261John Blangero · Texas Biomedical Research Institute · R37 · FY2009 · MH
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)
$741,038Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2023 · HL
Methyl Mercury Effect on Adolescent Development Renewal
$740,998Philip W Davidson · University Of Rochester · R01 · FY2011 · ES
Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosis
$740,989Douglas K Bowles · University Of Missouri-Columbia · R01 · FY2025 · HL